Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
CNBX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume4.45K
Average Volume (3M)72.53K
Market Cap
$331.02K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.82
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding31,111,353
10 Day Avg. Volume54,297
30 Day Avg. Volume72,525
Standard Deviation0.30
R-Squared0.04
Alpha-0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)11.48
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CNBX FAQ
What was CNBX Pharmaceuticals’s price range in the past 12 months?
CNBX Pharmaceuticals lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is CNBX Pharmaceuticals’s market cap?
CNBX Pharmaceuticals’s market cap is $331.02K.
When is CNBX Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CNBX Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is CNBX Pharmaceuticals overvalued?
According to Wall Street analysts CNBX Pharmaceuticals’s price is currently Overvalued.
Does CNBX Pharmaceuticals pay dividends?
CNBX Pharmaceuticals does not currently pay dividends.
What is CNBX Pharmaceuticals’s EPS estimate?
CNBX Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CNBX Pharmaceuticals have?
CNBX Pharmaceuticals has 31,111,353 shares outstanding.
What happened to CNBX Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CNBX Pharmaceuticals?
Currently, no hedge funds are holding shares in CNBX
---
Company Description
CNBX Pharmaceuticals
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.
---
Technical Analysis
---